FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2589740447> ?p ?o ?g. }

• W2589740447 abstract "The pathophysiological mechanisms of cisplatin nephrotoxicity include the reduction of renal blood flow, as well as tubular epithelial cell toxicity. The objective of this study was to investigate the influence of lower blood pressure and decreased food intake on the incidence of cisplatin nephrotoxicity. We conducted a retrospective cohort study at a university hospital between 2011 and 2012. We identified hospitalized adult patients with head and neck cancer, esophageal cancer, or gastric cancer, who received intravenous cisplatin administration. The primary outcome was the incidence of cisplatin nephrotoxicity defined as the increase in serum creatinine after cisplatin administration more than 1.5 times from baseline. The study participants included 182 patients, in whom we observed a total of 442 cycles of cisplatin chemotherapy. The incidence of cisplatin nephrotoxicity was observed in 41 of 182 cycles with initial administration. Multivariate logistic regression analysis showed that systolic blood pressure was independently associated with cisplatin nephrotoxicity (adjusted odds ratio 0.75, 95% confidence interval 0.57 to 0.95 for each 10 mmHg). The use of renin-angiotensin system (RAS) inhibitors was also associated with cisplatin nephrotoxicity (3.39, 1.30 to 8.93). Among quartiles of systolic blood pressure in all cycles of chemotherapy, the incidence of nephrotoxicity in the lower blood pressure group was significantly higher than that in the higher blood pressure group for patients taking non-solid food (P = 0.037), while there was no significant difference for patients taking solid food (P = 0.67). Lower blood pressure and the use of RAS inhibitors were associated with the incidence of cisplatin nephrotoxicity, and lower blood pressure had a greater influence on nephrotoxicity in patients who could not take solid food. Discontinuation of antihypertensive medication including RAS inhibitors before cisplatin chemotherapy should be considered, which may be beneficial for patients with lower blood pressure." @default.
• W2589740447 created "2017-03-03" @default.
• W2589740447 creator A5002965704 @default.
• W2589740447 creator A5008903518 @default.
• W2589740447 creator A5013983190 @default.
• W2589740447 creator A5017095541 @default.
• W2589740447 creator A5025761309 @default.
• W2589740447 creator A5028366589 @default.
• W2589740447 creator A5032180784 @default.
• W2589740447 creator A5038459903 @default.
• W2589740447 creator A5042074431 @default.
• W2589740447 creator A5042858128 @default.
• W2589740447 creator A5044772737 @default.
• W2589740447 creator A5045173926 @default.
• W2589740447 creator A5056941489 @default.
• W2589740447 creator A5066149050 @default.
• W2589740447 date "2017-02-20" @default.
• W2589740447 modified "2023-09-30" @default.
• W2589740447 title "Lower blood pressure and risk of cisplatin nephrotoxicity: a retrospective cohort study" @default.
• W2589740447 cites W1589849556 @default.
• W2589740447 cites W1593970288 @default.
• W2589740447 cites W1845746199 @default.
• W2589740447 cites W1937923399 @default.
• W2589740447 cites W1939012534 @default.
• W2589740447 cites W1961526782 @default.
• W2589740447 cites W1965256404 @default.
• W2589740447 cites W1969751148 @default.
• W2589740447 cites W1970814526 @default.
• W2589740447 cites W1976754856 @default.
• W2589740447 cites W1976768241 @default.
• W2589740447 cites W1983945804 @default.
• W2589740447 cites W1983965827 @default.
• W2589740447 cites W1996271706 @default.
• W2589740447 cites W2000886567 @default.
• W2589740447 cites W2003701831 @default.
• W2589740447 cites W2014455136 @default.
• W2589740447 cites W2034707276 @default.
• W2589740447 cites W2035290413 @default.
• W2589740447 cites W2063634819 @default.
• W2589740447 cites W2066030785 @default.
• W2589740447 cites W2069707552 @default.
• W2589740447 cites W2075395395 @default.
• W2589740447 cites W2082492249 @default.
• W2589740447 cites W2084492467 @default.
• W2589740447 cites W2090076608 @default.
• W2589740447 cites W2120641380 @default.
• W2589740447 cites W2125424757 @default.
• W2589740447 cites W2127618819 @default.
• W2589740447 cites W2135198134 @default.
• W2589740447 cites W2169486975 @default.
• W2589740447 cites W2267804050 @default.
• W2589740447 cites W2418594462 @default.
• W2589740447 cites W2465088510 @default.
• W2589740447 cites W2470345493 @default.
• W2589740447 cites W4250210754 @default.
• W2589740447 doi "https://doi.org/10.1186/s12885-017-3135-6" @default.
• W2589740447 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5319111" @default.
• W2589740447 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28219368" @default.
• W2589740447 hasPublicationYear "2017" @default.
• W2589740447 type Work @default.
• W2589740447 sameAs 2589740447 @default.
• W2589740447 citedByCount "26" @default.
• W2589740447 countsByYear W25897404472018 @default.
• W2589740447 countsByYear W25897404472019 @default.
• W2589740447 countsByYear W25897404472020 @default.
• W2589740447 countsByYear W25897404472021 @default.
• W2589740447 countsByYear W25897404472022 @default.
• W2589740447 countsByYear W25897404472023 @default.
• W2589740447 crossrefType "journal-article" @default.
• W2589740447 hasAuthorship W2589740447A5002965704 @default.
• W2589740447 hasAuthorship W2589740447A5008903518 @default.
• W2589740447 hasAuthorship W2589740447A5013983190 @default.
• W2589740447 hasAuthorship W2589740447A5017095541 @default.
• W2589740447 hasAuthorship W2589740447A5025761309 @default.
• W2589740447 hasAuthorship W2589740447A5028366589 @default.
• W2589740447 hasAuthorship W2589740447A5032180784 @default.
• W2589740447 hasAuthorship W2589740447A5038459903 @default.
• W2589740447 hasAuthorship W2589740447A5042074431 @default.
• W2589740447 hasAuthorship W2589740447A5042858128 @default.
• W2589740447 hasAuthorship W2589740447A5044772737 @default.
• W2589740447 hasAuthorship W2589740447A5045173926 @default.
• W2589740447 hasAuthorship W2589740447A5056941489 @default.
• W2589740447 hasAuthorship W2589740447A5066149050 @default.
• W2589740447 hasBestOaLocation W25897404471 @default.
• W2589740447 hasConcept C126189478 @default.
• W2589740447 hasConcept C126322002 @default.
• W2589740447 hasConcept C126894567 @default.
• W2589740447 hasConcept C156957248 @default.
• W2589740447 hasConcept C167135981 @default.
• W2589740447 hasConcept C2776694085 @default.
• W2589740447 hasConcept C2778239845 @default.
• W2589740447 hasConcept C2780091579 @default.
• W2589740447 hasConcept C2780306776 @default.
• W2589740447 hasConcept C71924100 @default.
• W2589740447 hasConcept C84393581 @default.
• W2589740447 hasConceptScore W2589740447C126189478 @default.
• W2589740447 hasConceptScore W2589740447C126322002 @default.
• W2589740447 hasConceptScore W2589740447C126894567 @default.
• W2589740447 hasConceptScore W2589740447C156957248 @default.
• W2589740447 hasConceptScore W2589740447C167135981 @default.

• next